Curevo

Curevo Vaccine

This clinical-stage biotechnology company develops next-generation subunit vaccines for shingles and chickenpox to serve adults and immunocompromised patients.

Simplexia

This company develops a vaccine against herpes simplex virus type 2 for patients with genital herpes infections.

CureAge

This company develops curative gene therapies for patients with neurofibromatosis type 1 and other peripheral nerve diseases using lipid nanoparticle technology.

GIVAX

This biotechnology company develops oral mucosal vaccines to protect children and adults against gastrointestinal diseases like rotavirus and norovirus.

Nykode Therapeutics

This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.

Sensible Biotechnologies

This company develops a cell-based platform to produce mRNA for pharmaceutical firms and biotechnology researchers developing therapeutics and vaccines.

Centivax

This company develops broad-spectrum vaccines and monoclonal antibodies using computational immune engineering to protect against infectious diseases and pathogens for global healthcare systems.

Jurata

This company develops thermostable thin-film formulations for vaccines and biologics, enabling needle-free administration and room-temperature storage for pharmaceutical manufacturers and healthcare providers.